About Us
Company establishment
Occupation of production workshop
Trypsin 10 tons/year
Chymotrypsin 10 tons/year
Pancreatic chymotrypsin 50 tons/year
Ribonuclease A 100kg/year
Beijing Geyuantianrun Bio-tech Co., Ltd., Ltd. is a national high-tech enterprise focusing on the international biopharmaceutical field, integrating R & D, production, sales and service, and a key foreign exchange income-generating enterprise of Beijing Municipal Commission of Commerce. The company's main products include trypsin, chymotrypsin, RNA-a enzyme and other functional biological enzymes and APIs. Geyuan Tianrun has always been adhering to the core concept of "quality is productivity", constantly innovating technology and products, and injecting new vitality into the high-quality development of world medicine with vigorous momentum.
View Details
To the beginning of the heart to the future to the quality of Bo development
Geyuan Tianrun always adheres to excellence, pursues excellent quality, makes full use of existing products and marketing advantages, integrates excellent technical strength, seizes the strategic opportunity of China's rapid economic development in the next ten years, and casts industry brands,

Quality Management
The company implements the advanced GMP (Good Manufacturing Practice for Drugs) management and detection system covering USP (United States Pharmacopoeia)/EP (European Pharmacopoeia)/CP (Chinese Pharmacopoeia)/BP (British Pharmacopoeia) standards. With its outstanding strength, the company has successfully passed the strict examination of FDA and DMF (Drug Master Document) registration, and has obtained USP certificate, ISO9001-2015 certificate and other certificates every year, highly recognized by many international authorities.
View Details
The company implements an advanced GMP (Good Manufacturing Practice) management and testing system that covers USP (United States Pharmacopeia) / EP (European Pharmacopoeia) / CP (Chinese Pharmacopoeia) / BP (British Pharmacopoeia) standards. With its outstanding capabilities, it has successfully passed the rigorous review by the US FDA and registered the DMF (Drug Master File). Each year, it obtains various certifications, including the USP certificate and ISO 9001 - 2015 certificate, receiving high recognition from multiple international authoritative organizations.

The multi-channel model realizes the transformation and industrialization of research and development achievements, providing customers with products and services with higher technological content.

The company strictly implements the operation of the quality system and ensures strict technical control over the execution of the quality system.
Honor










News Information
Industry Trends
05/16
Geyuan Tianrun invites you to meet at CPHI Shanghai Exhibition
From June 24 to 26, 2025, the global pharmaceutical industry event CPHI China will be grandly opened at the Shanghai New International Expo Center!
BGB Dynamics
01/07
Analysis of Global Pharmaceutical Product Market in 2020
According to the forecast of IMS, global pharmaceutical product trading volume in 2020 will reach 4.5 trillion unit doses, up 24% from 2015; the total spending is expected to exceed USD1.4 trillion, up 29%-32% from 2015.